A Multi-center, Single Arm Study of Enzalutamide in Patients With Progressive Metastatic Castration-Resistant Prostate Cancer Previously Treated With Abiraterone Acetate
Active, no longer recruiting
Phase of Trial: Phase IV
Latest Information Update: 12 Jun 2017
At a glance
- Drugs Enzalutamide (Primary)
- Indications Prostate cancer
- Focus Therapeutic Use
- Sponsors Astellas Pharma Europe Ltd
- 10 Jun 2017 Biomarkers information updated
- 06 Mar 2017 Planned End Date changed from 1 Mar 2017 to 1 Aug 2017.
- 18 Feb 2017 Results of 48 weeks data presented at the 2017 Genitourinary Cancers Symposium.